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General: Reactions were carried out under nitrogen in flame-dried glassware. 
Tris(dibenzylideneacetone)dipalladium was purchased from Strem Chemical Co. and 
used without further purification. Dichloromethane and toluene were purified using a 
GlassContour solvent system. Anhydrous dioxane was purchased from Acros Organics 
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in a sure seal bottle and used as received. All other solvents and aryl halides were 
purchased from commercial sources and used as received. 1-(But-3-en-1-
yl)cyclopentan-1-ol (1a),[1] 2,5-dimethylhex-5-en-2-ol (1d),[1] and (+)-(1S,2R)-2-
phenylcyclohexan-1-ol,[2] 4-methyl-2,2-diphenylpent-4-en-1-ol (5),[3] and ligands L1–L6[4] 
were synthesized according to literature procedures. 4-Penten-1-ol (1b) was purchased 
from commercial sources and was used without further purification. Yields refer to 
isolated compounds that are estimated to be >95% pure as judged by 1H NMR or GC 
analysis unless stated otherwise. The yields reported in the supporting information 
describe the result of a single experiment, whereas yields reported in Tables 2 and 3 
are average yields of two or more experiments. Thus, the yields reported in the 
supporting information may differ from those in the manuscript.  
 
Synthesis of Substrates: 
 
1,1-Diphenylpent-4-en-1-ol (1c).[5] A flame dried round bottom flask equipped with a 
stir bar was cooled under a stream of nitrogen and charged with 4-pentenoyl chloride (5 
mmol, 0.55 mL) and diethyl ether (50 mL). The mixture was cooled to 0 °C in an ice 
bath for five min and then PhMgBr (20 mL, 20 mmol, 1M in THF) was added dropwise 
to the flask. The resulting mixture was warmed to rt and stirred for 12 h, then the flask 
was cooled to 0 °C in an ice bath and slowly quenched with saturated aqueous 
ammonium chloride (10 mL). The mixture was transferred to a separatory funnel, the 
layers were separated, and the aqueous layer was extracted with ethyl acetate (3 x 25 
mL. The organic layers were combined, dried over anhydrous sodium sulfate, filtered, 
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and concentrated in vacuo. The crude product was then purified by flash 
chromatography on silica gel to afford the title compound (864 mg, 72%) as a colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 7.43 (d, J = 7.4 Hz, 4 H), 7.33 (t, J = 8.1 Hz, 4 H), 7.24 
(t, J = 6.6 Hz, 2 H), 6.85–6.78 (m, 2 H), 5.06–4.96 (m, 2 H), 2.44–2.38 (m, 2 H), 2.18 (s, 
1 H), 2.12–2.04 (m, 2 H). Spectroscopic data was consistent with that previously 
reported in the literature.[5] 
 
 
4-Methyl-1,1-diphenylpent-4-en-1-ol (1e). A flame dried round bottom flask equipped 
with a stir bar was cooled under a stream of nitrogen and charged with PhMgBr (25 mL, 
25 mmol, 1M in THF). The solution was cooled to 0 °C in an ice bath for five min. In a 
separate flask ethyl 4-methylpent-4-enoate[6] (1.0 g, 7 mmol) was dissolved in 20 mL 
anhydrous THF, and the resulting solution was added dropwise to the flask containing 
the cooled PhMgBr solution. The reaction mixture was then warmed to rt, stirred for 12 
h, then was cooled to 0 °C in an ice bath and slowly quenched with saturated aqueous 
ammonium chloride (20 mL). The resulting mixture was transferred to a separatory 
funnel, the layers were separated, and the aqueous layer was extracted with diethyl 
ether (3x25 mL). The organic layers were combined, dried over anhydrous sodium 
sulfate, filtered, and concentrated in vacuo. The crude product was then purified by 
flash chromatography on silica gel to afford the title compound (1.54 g, 88%) as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.43 (dd, J = 8.31, 0.98 Hz, 4 H), 7.34–7.31 
(m, 4H), 7.25–7.20 (m, 2 H), 4.73 (s, 1 H), 4.70 (s, 1 H), 2.48–2.42 (m, 2 H), 2.25 (s, br, 
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1 H), 2.06–1.99 (m, 2 H), 1.74 (s, 3 H); 13C NMR (175 MHz, CDCl3) δ 147.1, 146.4, 
128.4, 127.0, 126.2, 110.1, 78.5, 40.0, 32.2, 23.0; IR (film) 3469, 2932, 1446 cm-1; MS 
(EI) 252.1515 (252.1514 calcd for C18H20O, M +). 
 
 
(E)-1,1-Diphenylhex-4-en-1-ol (1f). The title compound was prepared from PhMgBr (50 
mL, 50 mmol, 1M in THF) and (E)-ethyl hex-4-enoate[7] (2.28 g, 16.0 mmol) using a 
procedure analogous to that described above for the synthesis of 1e. This procedure 
afforded the title compound (1.23 g, 30%) as a colorless solid, mp 53–54 °C: 1H NMR 
(500 MHz, CDCl3) δ 7.40–7.43 (m, 4 H), 7.28–7.33 (m, 4 H), 7.20–7.24 (m, 2 H), 5.37–
5.51 (m, 2 H), 2.33–2.38 (m, 2 H), 2.23 (s, 1 H), 1.96–2.03 (m, 2 H), 1.63 (dd, J = 5.9, 
1.0 Hz, 3 H); 13C NMR (175 MHz, CDCl3) δ 147.2, 131.3, 128.3, 127.0, 126.2, 125.7, 
78.6, 41.7, 27.3, 18.1; IR (film) 3556, 2958, 1446 cm-1; MS (EI) 252.1510 (252.1514 
calcd for C18H20O, M +). 
 
 
3-(Cyclohex-1-en-1-yl)-1,1-diphenylpropan-1-ol (1g). The title compound was 
prepared from PhMgBr (11 mL, 11 mmol, 1M in THF) and 3-(cyclohex-1-en-1-yl)-1-
phenylpropan-1-one[8] (1.2 g, 5.5 mmol) using a procedure analogous to that described 
above for the synthesis of 1e. This procedure afforded the title compound (600 mg, 
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37%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.39–7.49 (m, 4 H), 7.28–7.34 (m, 
4 H), 7.18–7.24 (m, 2 H), 5.41 (s, 1 H), 2.38–2.45 (m, 2 H), 2.37 (s, 1 H), 1.88–2.03 (m, 
6 H), 1.48–1.67 (m, 4 H); 13C NMR (175 MHz, CDCl3) δ 147.2, 138.2, 128.3, 126.9, 
126.2, 121.6, 78.7, 39.8, 32.5, 28.7, 25.4, 23.1, 22.7; IR (film) 3467, 2923, 1446 cm-1; 
MS (EI) 292.1823 (292.1827 calcd for C21H24O, M +). 
 
Synthesis of ligand L7.  
 
(–)-(1S,2R)-2-[(1,1'-Biphenyl)-4-yl]cyclohexan-1-ol (S1). A flame-dried 2-neck round 
bottom flask equipped with a stirbar and a reflux condenser was cooled under a stream 
of nitrogen and charged with magnesium turnings (1.76 g, 72 mmol) and THF (50 mL). 
A solution of 4-bromobiphenyl (11.65 g, 50 mmol) in THF (15 mL) was slowly added. 
The reaction mixture began to rapidly reflux, and the reaction temperature was 
controlled by placing the flask in an ice bath until reflux subsided. Once the magnesium 
turnings had disappeared, the reaction mixture was cooled to -20 °C for 10 min then 
CuCl (8 mol%) was added to the reaction mixture immediately followed by the addition 
of cyclohexene oxide (3.36 mL, 33.3 mmol) as a solution in THF (7 mL). The resulting 
mixture was allowed to slowly warm to rt and stirred for 4 h. The mixture was then 
cooled to 0 °C and quenched with saturated ammonium chloride (1mL/mmol 
cyclohexene oxide). The mixture was filtered through a pad of celite, and transferred to 
a separatory funnel. The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3x). The combined organic layers were then dried over sodium 
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sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel to afford 4.00 g (48 %) of (±)-S1 as a white solid.  
A flame dried round bottom flask equipped with a stirbar was cooled under a stream 
of nitrogen and charged with PS 30 Amano Lipase (14.8 mg), (±)-S1 (3.74 g, 14.8 
mmol) and tert-butyl methyl ether (45 mL). Neat vinyl acetate (13.6 mL, 148 mmol) was 
then added and the resulting mixture was stirred at rt until one enantiomer of the alcohol 
had been consumed as judged by chiral HPLC analysis (3 days). The mixture was then 
filtered through a fritted funnel and the enzyme was washed with diethyl ether and then 
recycled for future use (if desired). The resulting solution was concentrated in vacuo 
and the crude product was purified by flash chromatography on silica gel to afford 1.72 
g (46%) of the title compound as a white solid, mp 122–125 °C. This material was 
judged to be >99:1 er by chiral HPLC analysis (Chiracel OJH, 25 cm x 4.6 mm, 4% 
IPA/Hexanes, 1.00 mL/min, λ 254 nm, RT= 21.8 and 25.0 min). [α]23D  –13.99 (c 3.38, 
CH2Cl2); 1H NMR (700 MHz, CDCl3) δ 7.62–7.57 (m, 4 H), 7.45 (t, J = 7.7 Hz, 2 H), 
7.37–7.34 (m, 3 H), 3.72 (td, J = 10.0, 4.2 Hz, 1 H), 2.51 (td, J = 11.1, 3.6 Hz, 1 H), 2.1–
2.15 (m, 1 H), 1.95–1.88 (m, 2 H), 1.81 (app. d, J = 13.2 Hz, 1 H), 1.64–1.35 (m, 5 H); 
13C NMR (175 MHz CDCl3) δ 142.6, 141.1, 140.0, 128.9, 128.5, 127.7, 127.3, 127.2, 
74.6, 53.1, 34.5, 33.5, 26.2, 25.3; IR (film) 3548, 2919, 1490 cm-1; MS (ESI+) 270.1850 
(270.1852 calcd for C18H20O, M + NH4+).  
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(+)-(1S,2R,3aS,8aS)-6-{[-2-([1,1'-Biphenyl]-4-yl)cyclohexyl]oxy}-2’,2’-dimethyl-
4,4,8,8-Tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine (L7). 
The ligand was prepared according to a previously reported procedure for the synthesis 
of chiral phosphites.[4] A flame dried round bottom flask equipped with a stirbar was 
cooled under a stream of nitrogen and charged with (1S,2R)-2-([1,1'-biphenyl]-4-
yl)cyclohexan-1-ol (255 mg, 1.01 mmol), and dry dichloromethane (2 mL). Neat PCl3 (86 
µL, 1.01 mmol), was added and the resulting mixture was allowed to stir for 1 h at rt. 
After this time, anhydrous NEt3 (0.56 mL, 4.04 mmol) was added dropwise and the 
mixture was stirred at rt for 30 min. A solution of (S,S)-TADDOL (450 mg, 0.963 mmol) 
in dichloromethane (2 mL) was added, and the reaction mixture was stirred at rt for 12 
h. The mixture was then diluted with diethyl ether (20 mL) and then filtered through 
celite. The solvent was evaporated in vacuo and the crude product was purified by flash 
chromatography on silica gel to afford 520 mg (72%) of the title compound as a white 
foamy solid, mp 115–118 °C.  [α]23D  +130.0 (c 5.81, CH2Cl2); 1H NMR (700 MHz, 
CDCl3) δ 7.51 (d, J = 7.9 Hz, 2 H), 7.38–7.02 (m, 27 H), 4.94–4.90 (m, 1 H), 4.88 (d, J = 
8.4 Hz, 1 H), 4.56 (app. qd, J = 9.9, 3.7 Hz, 1 H), 2.71–2.66 (m, 1 H), 2.28 (app. d, J = 
13.8 Hz, 1 H), 1.95 (app. d, J = 13.2 Hz, 1 H), 1.81–1.73 (m, 2 H), 1.69–1.50 (m, 2 H), 
1.41–1.31 (m, 2 H), 1.19 (s, 3 H), 0.30 (s, 3 H); 13C NMR (175 MHz CDCl3) δ 146.6, 
146.1, 143.0, 141.8, 141.25, 141.23, 139.4, 129.4, 129.0, 128.92, 128.89, 128.6, 128.0, 
127.8, 127.54, 127.48, 127.45, 127.38, 127.34, 127.30, 127.18, 127.15, 127.12, 127.06, 
126.9, 112.0, 82.9, 82.7, 82.6, 82.12, 82.10, 81.92, 81.88, 78.10, 78.09, 51.39, 51.37, 
35.7, 33.8, 27.6, 26.0, 25.5, 25.3 (due to the complexity of the spectra all the peaks are 
listed without assigning C-P couplings); 31P NMR (202 MHz CDCl3) δ 140.6; IR (film) 
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2932, 1486, 1447 cm-1; MS (ESI+) 747.3224 (747.3234 calcd for C49H47O5P, M + H+). 
 
General procedure for asymmetric Pd-catalyzed carboalkoxylation reactions. A 
flame-dried Schlenk tube equipped with a stirbar was cooled under a stream of nitrogen 
and charged with Pd2(dba)3 (2 mol %), L7 (5 mol %), the alcohol substrate (1.0 equiv), 
and NaOtBu (1.50–2.0 equiv). The flask was purged with N2 then the aryl or alkenyl 
halide (1.40–2.0 equiv), and dioxane or toluene (0.10 M) was added. The resulting 
mixture was heated to 90 °C with stirring until the starting material had been consumed 
as judged by TLC analysis (ca. 12 h). The reaction mixture was then cooled to rt, 
saturated aqueous ammonium chloride (6 mL/mmol substrate) was added, and the 
mixture was transferred to a separatory funnel. The mixture was extracted with ethyl 
acetate (3 x 5 mL) then the combined organic layers were dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel. 
 
 
(+)-(S)-2-(Naphthalen-2-ylmethyl)-1-oxaspiro[4.4]nonane (2a). The general 
procedure was employed for the coupling of 1-(but-3-en-1-yl)cyclopentan-1-ol (28.0 mg, 
0.20 mmol) and 2-bromonaphthalene (75.0 mg, 0.36 mmol) using a catalyst composed 
of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature 
of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure afforded the title 
compound (31.1 mg, 58%, 10:1 regioselectivity) as a colorless oil: [α]23D +12.4(c 2.1, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.85–7.79 (m, 3 H), 7.67 (s, 1 H), 7.49–7.35 (m, 3 
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H), 4.29–4.22 (m, 1 H), 3.15 (dd, J = 13.6, 5.0 Hz, 1 H), 2.87 (dd, J = 13.3, 7.7 Hz, 1 H), 
1.95–1.87(m, 1 H), 1.86–1.49 (m, 11 H); 13C NMR (125 MHz, CDCl3) δ 136.6, 133.7, 
132.3, 128.4, 127.84, 127.79, 127.75, 127.7, 91.6, 79.2, 43.0, 39.4, 38.6, 36.6, 24.2; IR 
(film) 2953, 2361, 2338, 1508 cm-1. MS (CI) 267.1743 (267.1743 calcd for C19H22O, M + 
H+). The enantiopurity was determined to be 89:11 er by chiral HPLC analysis (Chiralcel 
OJH, 25 cm x 4.6 mm, 1% IPA/Hexanes, 1.00 mL/min, λ 254 nm, RT= 10.5 and 12.8 
min). 
 
 
(+)-(S)-2-(Naphthalen-2-ylmethyl)-1-oxaspiro[4.4]nonane (2b). The general 
procedure was employed for the coupling of 1-(but-3-en-1-yl)cyclopentan-1-ol (28 mg, 
0.20 mmol) and 4-bromobenzophenone (94 mg, 0.36 mmol) using a catalyst composed 
of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature 
of 90 °C, and a reaction time of 12 h in 2mL of dioxane. This procedure afforded the title 
compound (34.6 mg, 53%, 6:1 regioselectivity) as a clear oil: [α]23D +21.9 (c 1.77, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.80–7.77 (m, 2 H), 7.74 (d, J = 8.1 Hz, 2 H), 
7.57 (t, J = 7.3 Hz, 1 H), 7.49–7.45 (m, 2 H), 7.34 (d, J = 8.3 Hz, 2 H),  4.19 (app. quint, 
J = 6.6 Hz, 1 H), 3.01 (dd, J = 13.4, 5.6 Hz, 1 H), 2.80 (dd, J = 13.4, 6.8 Hz, 1 H), 1.96–
1.90 (m, 1 H), 1.83–1.48 (m, 11 H); 13C NMR (125 MHz, CDCl3) δ 196.5, 144.1, 137.9, 
132.2, 130.1, 129.9, 129.4, 128.3, 128.2, 127.6, 91.5. 78.5, 42.7, 39.2, 38.4, 36.4, 31.3, 
24.0, 23.9; IR (film) 2959, 1655, 1606, 1277 cm-1. MS (CI) 321.1848 (321.1849 calcd for 
C22H24O2, M + H+). The enantiopurity was determined to be 82:18 er by chiral HPLC 
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analysis (Chiralcel ADH, 25 cm x 4.6 mm, 1% IPA/Hexanes, 1.00 mL/min, λ 254 nm, 
RT= 17.4 and 18.4 min). 
 
 
(+)-(S)-2-(Naphthalen-2-ylmethyl)tetrahydrofurantetrahydrofuran (2c). The general 
procedure was employed for the coupling of pent-4-en-1-ol (17 mg, 0.20 mmol) and 2-
bromonaphthalene (58 mg, 0.28 mmol) using a catalyst composed of Pd2(dba)3 (3.7 mg, 
0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature of 90 °C, and a 
reaction time of 12 h in 2mL of dioxane. This procedure afforded the title compound (9.9 
mg, 23%) as a light yellow oil. [α]23D= +2.1 (c 0.95, CH2Cl2); 1H NMR (500 MHz, CDCl3) 
δ 7.83–7.75 (m, 3 H), 7.68 (s, 1 H), 7.48–7.36 (m, 3 H), 4.18 (app. quint, J = 6.5 Hz, 1 
H), 3.95–3.89 (m, 1 H), 3.79–3.73 (m, 1 H), 3.08 (dd, J = 13.5, 6.4 Hz, 1 H), 2.92 (dd, J 
= 13.7, 6.4 Hz, 1 H), 1.98–1.82 (m, 3 H), 1.66–1.57 (m, 1 H). Other spectroscopic data 
matched those previously reported.[1] The enantiopurity was determined to be 58:42 er 
by chiral HPLC analysis (Chiralcel OJH, 25 cm x 4.6 mm, 1% IPA/Hexanes, 1.50 
mL/min, λ 254 nm, RT= 19.8 and 26.1 min). 
 
 
(+)-(S)-5-(Naphthalen-2-ylmethyl)-2,2-diphenyltetrahydrofuran (2d). The general 
procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-ol (48 mg, 0.20 
mmol) and 2-bromonaphthalene (58 mg, 0.28 mmol) using a catalyst composed of 
Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature of 
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90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure afforded the title 
compound (48.7mg, 67%) as a white solid, mp 83–86 °C. [α]23D +29.6 (c 4.24, CH2Cl2); 
1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.2 Hz, 1 H), 7.81 (d, J = 8.6 Hz, 2 H), 7.74 (s, 
1 H), 7.55–7.44 (m, 7 H), 7.37–7.31 (m, 4 H), 7.28–7.21 (m, 2 H), 4.53 (app. quint, J = 
6.7 Hz, 1 H), 3.34 (dd, J = 13.6, 6.0 Hz, 1 H), 3.02 (dd, J = 13.6, 7.0 Hz, 1 H), 2.71–2.64 
(m, 1 H), 2.58–2.51 (m, 1 H), 2.03–1.95 (m, 1 H), 1.89–1.81 (m, 1 H); 13C NMR (125 
MHz, CDCl3) δ 147.4, 146.9, 136.6, 133.7, 132.3, 128.31, 128.25, 128.2, 127.88, 
127.87, 127.8, 127.6, 126.76, 126.74, 126.1, 126.0, 125.4, 88.5, 79.9, 42.8, 38.8, 31.0; 
IR (film) 2934, 1601, 1446 cm-1. MS (CI) 365.1899 (365.1900 calcd for C27H24O, M + 
H+). The enantiopurity was determined to be 95:5 er by chiral HPLC analysis (Chiralcel 
ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 254 nm, RT= 5.2 and 6.3 min). 
When 2.0 equiv of H2O was added with toluene as solvent the enantiopurity was 
determined to be 96:4 er. 
 
 
(+)-(S)-{4-[(5,5-diphenyltetrahydrofuran-2-yl)methyl]phenyl}(phenyl)methanone 
(2e). The general procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-
ol (48 mg, 0.20 mmol) and 4-bromobenzophenone (94 mg, 0.36 mmol) using a catalyst 
composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction 
temperature of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure 
afforded the title compound (52 mg, 62%) as a colorless oil. [α]23D +18.9 (c 2.40, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.82–7.78 (m, 2 H), 7.75 (d, J = 8.1 Hz, 2 H), 
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7.59 (t, J = 7.2 Hz, 1 H), 7.51–7.40 (m, 6 H), 7.38 (d, J = 8.1 Hz, 2 H),  7.31–7.25 (m, 4 
H), 7.22–7.17 (m, 2 H),  4.42 (app. quint, J = 6.6 Hz, 1 H), 3.16 (dd, J = 13.6, 6.6 Hz, 1 
H), 2.91 (dd, J = 13.7, 6.4 Hz, 1 H), 2.68–2.61 (m, 1 H), 2.54–2.47 (m, 1 H), 2.03–1.96 
(m, 1 H), 1.81–1.73 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 196.7, 147.2, 146.7, 144.2, 
138.0, 135.7, 132.4, 130.4, 130.2, 129.5, 128.40, 128.35, 128.2, 126.83, 126.80, 126.0, 
125.9, 88.6, 79.5, 42.7, 38.7, 31.2; IR (film) 2362, 1654, 1446 cm-1. MS (CI) 419.2006 
(419.2006 calcd for C30H26O2, M + H+). The enantiopurity was determined to be 92:8 er 
by chiral HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 5% IPA/Hexanes, 1.00 
mL/min, λ 254 nm, RT= 9.8 and 11.7 min). When 2.0 equiv of H2O was added with 
toluene as solvent the enantiopurity was determined to be 95:5 er (an unknown product 
co-eluted when water was used with this reaction see spectra for product 2e below.) 
 
 
(+)-(S)-5-[(6-methoxynaphthalen-2-yl)methyl]-2,2-diphenyltetrahydrofuran (2f). The 
general procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-ol (48 mg, 
0.20 mmol) and 2-bromo-6-methoxynaphthalene (85 mg, 0.36 mmol) using a catalyst 
composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction 
temperature of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure 
afforded the title compound (52 mg, 66%) as a white solid, mp 93–96 °C. [α]23D +29.8 (c 
5.19, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.69 (app. dd, J = 8.6, 3.2 Hz, 2 H), 7.65 (s, 
1 H), 7.53–7.46 (m, 4 H), 7.69 (d, J = 8.4 Hz, 1 H), 7.36–7.28 (m, 4 H), 7.27–7.13 (m, 4 
H), 4.50 (app. quint, J = 6.7 Hz, 1 H), 3.94 (s, 3H), 3.29 (dd, J = 13.7, 5.9 Hz, 1 H), 2.97 
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(dd, J = 13.7, 7.1 Hz, 1 H), 2.69–2.61 (m, 1 H), 2.55–2.48 (m, 1 H), 2.00–1.93 (m, 1 H), 
1.87–1.79 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 157.4, 147.4, 146.9, 134.2, 133.3, 
129.2, 128.6, 128.3, 128.2, 127.7, 126.74, 126.72, 126.1, 126.0, 118.8, 105.8, 88.5, 
80.0, 55.4, 42.6, 38.8, 30.9; IR (film) 2937, 1605, 1448 cm-1. MS (CI) 395.2004 
(395.2006 calcd for C28H26O2, M + H+). The enantiopurity was determined to be 95:5 er 
by chiral HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 
mL/min, λ 254 nm, RT= 7.5 and 8.9 min). 
 
 
(+)-(S)-5-(4-Methoxybenzyl)-2,2-diphenyltetrahydrofuran (2g). The general 
procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-ol (48 mg, 0.20 
mmol) and 4-bromoanisole (46 µL, 0.36 mmol) using a catalyst composed of Pd2(dba)3 
(3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature of 90 °C 
and a reaction time of 12 h in 2 mL of dioxane. This procedure afforded the title 
compound (45.0 mg, 65%) as a colorless oil: [α]23D +24.5 (c 2.00, CH2Cl2); 1H NMR 
(700 MHz, CDCl3) δ 7.47–7.42 (m, 4 H), 7.30–7.26 (m, 4 H), 7.21–7.15 (m, 4 H), 6.82 
(d, J = 8.6 Hz, 2 H), 4.33 (app. quint, J = 6.6 Hz, 1 H), 3.79 (s, 3 H), 3.08 (dd, J = 13.6, 
5.8 Hz, 1 H), 2.74 (dd, J = 13.7, 7.2 Hz, 1 H), 2.64–2.59 (m, 1 H), 2.50–2.45 (m, 1 H), 
1.95–1.89 (m, 1 H), 1.76–1.70 (m, 1 H); 13C NMR (175 MHz, CDCl3) δ 158.2, 147.4, 
146.9, 131.1, 130.5, 128.3, 128.1, 126.73, 126.70, 126.1, 126.0, 113.9, 88.4, 80.2, 55.4, 
41.8, 38.8, 30.9; IR (film) 2936, 1606, 1512 cm-1. MS (CI) 345.1847 (345.1855 calcd for 
C24H24O2, M + H+). The enantiopurity was determined to be 94:6 er by chiral HPLC 
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analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 254 nm, 
RT= 7.5 and 8.9 min). 
 
 
(+)-(S)-1-Benzyl-5-[(5,5-diphenyltetrahydrofuran-2-yl)methyl]-1H-indole (2h). The 
general procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-ol (48 mg, 
0.20 mmol) and 1-benzyl-5-bromo-1H-indole (103 mg, 0.36 mmol) using a catalyst 
composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction 
temperature of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure 
afforded the title compound (63.5 mg, 72%) as a colorless oil: [α]23D +14.7 (c 6.00, 
CH2Cl2); 1H NMR (700 MHz, CDCl3) δ 7.54–7.46 (m, 5 H), 7.33–7.25 (m, 7 H), 7.23–
7.18 (m, 3 H), 7.15–7.08 (m, 4 H), 6.50 (d, J = 3.1 Hz, 1 H), 5.30 (s ,2 H), 4.44 (app. 
quint, J = 6.7 Hz, 1 H), 3.30 (dd, J = 13.5, 5.4, Hz 1 H), 2.88 (dd, J = 13.5, 7.9 Hz, 1 H), 
2.65–2.60 (m, 1 H), 2.55–2.50 (m, 1 H), 1.95–1.89 (m, 1 H), 1.84–1.78 (m, 1 H); 13C 
NMR (175 MHz, CDCl3) δ 147.5, 147.0, 137.8, 135.3, 130.0, 129.0, 128.9, 128.3, 128.1, 
127.7, 127.0, 126.68, 126.66, 126.13, 126.08, 123.7, 121.4, 109.5, 101.5, 88.4, 80.9, 
50.3, 42.8, 38.9, 30.9; IR (film) 2923, 1485, 1446 cm-1. MS (CI) 444.2319 (444.2322 
calcd for C32H29NO, M + H+). The enantiopurity was determined to be 93:7 er by chiral 
HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 254 
nm, RT= 10.8 and 21.3 min). 
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(+)-(S)-Phenyl{4-[(2,5,5-trimethyltetrahydrofuran-2-yl)methyl]phenyl}methanone 
(2j). The general procedure was employed for the coupling of 2,5-dimethylhex-5-en-2-
ol1 (26 mg, 0.20 mmol) and 4-bromobenzophenone (94 mg, 0.36 mmol) using a catalyst 
composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction 
temperature of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure 
afforded the title compound (51.0 mg, 77%) as a colorless oil: [α]23D +3.48 (c 7.10, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.76–7.82 (m, 2 H), 7.73 (d, J = 8.1 Hz, 2 H), 
7.54–7.60 (m, 1 H), 7.47 (t, J = 10.0 Hz, 2 H), 7.35 (d, J = 8.1 Hz, 2 H), 2.85 (s, 2 H), 
1.95–2.03 (m, 1 H), 1.76–1.85 (m, 2 H), 1.56–1.66 (m, 1 H), 1.25 (d, J = 2.9 Hz, 6 H), 
1.14 (s, 3 H); 13C NMR (175 MHz, CDCl3) δ 196.8, 143.9, 138.1, 135.6, 132.3, 130.8, 
130.1, 129.9, 128.4, 83.3, 81.7, 48.5, 38.6, 36.7, 29.9, 29.4, 28.6; IR (film) 2966, 1654, 
1277 cm-1; MS (ESI+) 309.1847 (309.1849 calcd for C21H24O2, M + H+). The 
enantiopurity was determined to be 38:62 er by chiral HPLC analysis (Chiralcel ADH, 25 
cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 195 nm, RT= 10.1 and 10.8 min). 
 
 
(+)-(S)-{4-[(2-Methyl-5,5-diphenyltetrahydrofuran-2 
yl)methyl]phenyl}(phenyl)methanone (2k). The general procedure was employed for 
the coupling of 4-methyl-1,1-diphenylpent-4-en-1-ol (51 mg, 0.20 mmol) and 4-
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bromobenzophenone (94 mg, 0.36 mmol) using a catalyst composed of Pd2(dba)3 (3.7 
mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature of 90 °C and a 
reaction time of 12 h in 2mL of dioxane. This procedure afforded the title compound 
(74.8 mg, 86%) as a colorless solid, mp 89–91 °C: [α]23D +20.9 (c 6.30, CH2Cl2); 1H 
NMR (500 MHz, CDCl3) δ 7.79–7.86 (m, 2 H), 7.72 (d, J = 8.1 Hz, 2 H), 7.58–7.64 (m, 1 
H), 7.46–7.54 (m, 6 H), 7.26–7.40 (m, 6 H), 7.16–7.25 (m, 2 H), 3.03 (d, J = 13.2 Hz, 1 
H), 2.91 (d, J = 13.2 Hz, 1 H), 2.62–2.75 (m, 2 H), 2.09 (m, 1 H), 1.86 (m 1 H), 1.31 (s, 3 
H); 13C NMR (175 MHz, CDCl3) δ 196.7, 148.2, 147.7, 143.8, 138.0, 135.6, 132.3, 
130.6, 130.1, 129.9, 128.4, 128.1, 128.1, 126.7, 126.5, 126.0, 125.8, 88.7, 84.6, 48.5, 
38.4, 37.4, 27.2; IR (film) 2966, 1654, 1277 cm-1; MS (ESI+) 433.2160 (433.2162 calcd 
for C31H28O2, M + H+). The enantiopurity was determined to be 95:5 er by chiral HPLC 
analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 275 nm, 
RT= 15.4 and 18.1 min). 
 
 
(+)-(S)-1-Benzyl-5-[(2-methyl-5,5-diphenyltetrahydrofuran-2-yl)methyl]-1H-indole 
(2l). The general procedure was employed for the coupling of 4-methyl-1,1-
diphenylpent-4-en-1-ol (51 mg, 0.20 mmol) and 1-benzyl-5-bromo-1H-indole (103 mg, 
0.36 mmol) using a catalyst composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 
mg, 0.010 mmol), a reaction temperature of 90 °C and a reaction time of 12 h. This 
procedure afforded the title compound (80.5 mg, 88%) as a colorless solid, mp 127–128 
°C : [α]23D +22.6 (c 6.91, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ = 7.43–7.51 (m, 5 H), 
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7.22–7.33 (m, 10 H), 7.10–7.20 (m, 5 H), 7.08 (d, J = 3.2 Hz, 1 H), 7.04 (dd, J = 8.4, 1.6 
Hz, 1 H), 6.46 (d, J = 3.2 Hz, 1 H), 5.29 (s, 2 H), 3.04 (d, J = 13.4 Hz, 1 H), 2.90 (d, J = 
13.4 Hz, 1 H), 2.62–2.66 (m, 2 H), 2.06–2.13 (m, 1 H), 1.67–1.75 (m, 1 H), 1.26 (s, 3 H); 
13C NMR (125 MHz, CDCl3) δ 148.5, 148.1, 137.8, 135.3, 129.8, 128.9, 128.7, 128.3, 
128.1, 128.0, 127.7, 127.0, 126.5, 126.4, 126.2, 126.0, 124.8, 122.5, 109.1, 101.5, 88.4, 
85.4, 50.2, 48.5, 38.8, 36.9, 27.1; IR (film) 2924, 1485, 1447 cm-1; MS (ESI+) 458.2478 
(458.2478 calcd for C33H31NO, M + H+). The enantiopurity was determined to be 96:4 er 
by chiral HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 1% IPA/Hexanes, 1.00 
mL/min, λ 254 nm, RT= 11.6 and 30.3 min). 
 
 
(+)-(S)-4-{4-[(2-Methyl-5,5-diphenyltetrahydrofuran-2-yl)methyl]phenyl}morpholine 
(2m). The general procedure was employed for the coupling of 4-methyl-1,1-
diphenylpent-4-en-1-ol (51 mg, 0.20 mmol) and 4-(4-bromophenyl)morpholine (87 mg, 
0.36 mmol) using a catalyst composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 
mg, 0.010 mmol), a reaction temperature of 90 °C and a reaction time of 12 h in 2 mL of 
dioxane. This procedure afforded the title compound (68.0 mg, 82%) as a colorless 
solid, mp 143–145 °C : [α]23D +28.8 (c 6.70, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.47 
(dd, J = 12.8, 7.5 Hz, 4 H), 7.22–7.33 (m, 4 H), 7.13–7.19 (m, 2 H), 7.12 (d, J = 8.3 Hz, 
2 H), 6.79 (d, J = 8.3 Hz, 2 H), 3.87 (t, J = 4.7 Hz, 4 H), 3.09–3.14 (m, 4 H), 2.88 (d, J = 
13.5 Hz, 1 H), 2.74 (d, J = 13.5 Hz, 1 H), 2.59–2.68 (m, 2 H), 1.98–2.03 (m, 1 H), 1.69–
1.74 (m, 1 H), 1.23 (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 149.7, 148.4, 148.0, 131.3, 
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130.3, 128.1, 128.0, 126.5, 126.5, 126.1, 125.9, 115.4, 88.4, 85.1, 67.1, 49.7, 47.6, 
38.7, 37.0, 27.0; IR (film) 2966, 1515, 1446 cm-1; MS (ESI+) 414.2427 (414.2428 calcd 
for C28H31NO2, M + H+). The enantiopurity was determined to be 93:7 er by chiral HPLC 
analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, λ 210 nm, 
RT= 8.7 and 10.7 min). 
 
 
(+)-(S)-4-[(2-Methyl-5,5-diphenyltetrahydrofuran-2-yl)methyl]benzonitrile (2n).  The 
general procedure was employed for the coupling of 4-methyl-1,1-diphenylpent-4-en-1-
ol (51 mg, 0.20 mmol) and 4-bromobenzonitrile (66 mg, 0.36 mmol) using a catalyst 
composed of Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction 
temperature of 90 °C and a reaction time of 12 h in 2mL of dioxane. This procedure 
afforded the title compound (27.0 mg, 38%) as a colorless solid, mp 100–104 °C: [α]23D 
+23.9 (c 2.00, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 8.1 Hz, 2 H), 7.38–
7.42 (m, 4 H), 7.27–7.30 (m, 4 H), 7.22–7.25 (m, 2 H), 7.13–7.22 (m, 2 H), 2.90–2.95 (d, 
J = 13.5 Hz, 1 H), 2.79–2.85 (d, J = 13.5 Hz, 1 H), 2.55–2.67 (m, 2 H), 1.96–2.02 (m, 1 
H), 1.79–1.86 (m, 1 H), 1.23  (s, 3 H); 13C NMR (125 MHz, CDCl3) δ 148.1, 147.4, 
144.2, 131.7, 131.4, 128.2, 128.2, 126.8, 126.6, 126.0, 125.7, 119.4, 110.1, 88.8, 84.3, 
48.5, 38.2, 37.5, 27.3; IR (film) 2925, 2223, 1607 cm-1; MS (ESI+) 376.1670 (376.1670 
calcd for C25H23NO, M + Na+). The enantiopurity was determined to be 87:13 er by 
chiral HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 2% IPA/Hexanes, 1.00 mL/min, 
λ 195 nm, RT= 7.5 and 8.4 min). 
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(+)-(R)-{4-[(2-Methyl-4,4-diphenyltetrahydrofuran-2-
yl)methyl]phenyl}(phenyl)methanone (6). The general procedure was employed for 
the coupling of 4-methyl-2,2-diphenylpent-4-en-1-ol[3] (51 mg, 0.20 mmol) and (4-
bromophenyl)(phenyl)methanone (94 mg, 0.36 mmol) using a catalyst composed of 
Pd2(dba)3 (3.7 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a reaction temperature of 
90 °C, and a reaction time of 12 h in 2mL of dioxane. This procedure afforded the title 
compound (73 mg, 84%) as a light yellow oil. [α]23D= +0.01 (c 5.9, CH2Cl2); 1H NMR 
(500 MHz, CDCl3) δ 7.57–7.62 (m, 1 H), 7.46–7.52 (m, 2 H), 7.26–7.36 (m, 11 H), 7.16–
7.22 (m, 2 H), 4.53 (d, J = 9.5 Hz, 1 H), 4.39 (d, J = 9.5 Hz, 1 H), 2.90 (d, J = 13.2 Hz, 1 
H), 2.81 (d, J = 12.7 Hz, 1 H), 2.73 (d, J = 13.2 Hz, 1 H), 2.61 (d, J = 12.7 Hz, 1 H), 1.12 
(s, 3 H); 13C NMR (125 MHz, CDCl3) δ 196.7, 146.5, 143.4, 138.0, 135.7, 132.4, 130.6, 
130.1, 130.0, 128.6, 128.5, 128.4, 127.3, 126.4, 126.4, 83.7, 75.5, 56.5, 50.3, 47.8, 
26.9; IR (film) 2926.7, 2247, 1654, 1276 cm-1; MS (ESI+) 433.2164 (433.2162 calcd for 
C31H28O2, M + H+). The enantiopurity was determined to be 51:49 er by chiral HPLC 
analysis (Chiralcel ADH, 25 cm x 4.6 mm, 5% IPA/Hexanes, 1.00 mL/min, λ 254 nm, 
RT= 15.6 and 21.3 min). 
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Determination of absolute configuration: 
    Product 2i was synthesized according to general procedure D. The optical rotation of 
this compound ([α]23D +4.54 (c 0.22, CHCl3)); was compared with that in the literature[9] 
(lit[α]23D +8.30 (c 0.6, CHCl3)). Both compounds were dextrorotatory, thus 2i was 
assigned the (S) configuration on this basis. 
 
 
(+)-(S,E)-5-[3-(4-Methoxyphenyl)allyl]-2,2-diphenyltetrahydrofuran (2i): The general 
procedure was employed for the coupling of 1,1-diphenylpent-4-en-1-ol (48 mg, 0.20 
mmol) and (E)-1-(2-bromovinyl)-4-methoxybenzene (85 mg, 0.40 mmol) using a catalyst 
composed of 2 mol % Pd2(dba)3 (3.6 mg, 0.004 mmol) and L7 (7.5 mg, 0.010 mmol), a 
reaction temperature of 90 °C and a reaction time of 12 h. This procedure afforded the 
title compound (14 mg, 18 %) as a colorless oil. [α]23D +4.54 (c 0.22, CHCl3); lit[9][α]23D 
+8.30 (c 0.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 7.5 Hz, 4 H), 7.33–7.23 
(m, 6 H), 7.22–7.15 (m, 2 H), 6.83 (d, J = 8.8 Hz, 2 H), 6.40 (d, J = 16.0 Hz, 1 H), 6.83 
(dt, J = 15.7, 7.0 Hz, 1 H), 4.31–4.21 (m, 1 H), 3.80 (s, 3 H), 2.70–2.58 (m, 2 H), 2.57–
2.40 (m, 2 H), 2.06–1.86 (m, 1 H), 1.81–1.70 (m, 1 H). Other spectroscopic data 
matched that of the literature.[9] The enantiopurity was determined to be 79:21 er by 
chiral HPLC analysis (Chiralcel ADH, 25 cm x 4.6 mm, 0.5% IPA/Hexanes, 1.00 
mL/min, λ 254 nm, RT= 17.5 and 18.8 min). 
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Screen of Chiral TADDOL-Derived Phosphite Ligands: 
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